認知/記憶增強藥物市場：按藥物類型、應用分類 - 全球預測 2025-2030

2023年認知與記憶增強藥物市值為59.3億美元，預計到2024年將達到64.9億美元，複合年成長率為9.57%，到2030年將達到112.5億美元。

認知和記憶增強藥物通常稱為精神藥物，是一種旨在透過多種機制改善心理表現、針對記憶、注意力、動機和其他執行功能的藥物和補充品。工作量的增加和人口老化加劇了對這些藥物的需求，年輕的專業人士希望在競爭環境中獲得優勢，而老年人則尋求減輕與老齡化相關的認知能力下降，這推動了認知增強的需求。最終用途包括醫療保健、治療阿茲海默症和注意力不足過動症等神經系統疾病，以及提高學術和勞動力表現。市場開拓受到心理健康意識增強、藥物配方技術進步、主要企業研發投資增加等因素的影響。機會存在於開發副作用較少的化合物、擴大天然和有機產品線以及瞄準亞洲和拉丁美洲的新興市場。

然而，關於認知增強劑非醫療用途的嚴格法律規範和倫理問題構成了重大挑戰。與長期使用相關的副作用和潛在的濫用會進一步阻礙生長。最佳創新領域包括開發將藥理學進步與數位治療方法相結合的綜合解決方案，透過基因分析探索個人化醫療方法，以及增強遞送機制以提高生物有效性。該市場競爭激烈，其特點是快速的技術交流和不斷湧入的新興企業對老牌製藥巨頭構成挑戰。專注於永續和道德開發產品的創新和研究可能會成為進步和接受背後的驅動力。為了利用這些機會，公司應該投資與學術界和行銷部門的策略夥伴關係關係，以教育潛在消費者有關促智藥的益處和安全性。市場動態發展的本質需要敏捷性和持續適應不斷變化的消費者期望和監管環境。

市場動態：揭示快速發展的認知和記憶增強藥物市場的關鍵市場洞察

供需的動態交互作用正在改變認知和記憶增強藥物市場。了解這些不斷變化的市場動態可以幫助企業做出明智的投資決策、策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，並了解消費行為及其對製造成本的影響，並更清楚地了解對採購趨勢的影響。

• 市場促進因素
  • 越來越多的人患有神經退化性疾病
  • 老年人口增加
  • 更多考慮認知和記憶增強藥物在學術和體育方面的應用
• 市場限制因素
  • 藥物研發成本高
• 市場機會
  • 新藥和治療方法的開發
  • 政府核准開發新藥
• 市場挑戰
  • 副作用的風險

波特的五種力量策略工具駕馭認知與記憶增強藥物市場

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解認知和記憶增強藥物市場的外部影響

外部宏觀環境因素在塑造認知和記憶增強藥物市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解認知/記憶增強劑市場的競爭狀況

認知和記憶增強藥物市場的詳細市場佔有率分析可以對供應商的績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的見解，以應對日益激烈的競爭。

FPNV 定位矩陣認知與記憶增強藥物市場供應商的績效評估

FPNV 定位矩陣是評估認知和記憶增強藥物市場供應商的重要工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。這四個象限使您能夠清晰、準確地分類供應商，以確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議，描繪認知和記憶增強藥物市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，對認知和記憶增強藥物市場的策略分析至關重要。透過考慮關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：對當前市場環境的詳細審查、主要企業的廣泛資料、對其在市場中的影響力和整體影響力的評估。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

• 市場動態
  • 促進因素
    • 越來越多的人患有神經退化性疾病
    • 老年人口增加
    • 更多考慮認知和記憶增強藥物在學術和體育方面的應用
  • 抑制因素
    • 藥物研發高成本
  • 機會
    • 新藥和治療方法的開發
    • 政府核准開發新藥
  • 任務
    • 副作用的風險
• 市場區隔分析
• 波特五力分析
• PESTEL分析
  • 政治的
  • 經濟
  • 社群
  • 技術的
  • 合法地
  • 環境

第6章依藥物類型分類的認知/記憶增強藥物市場

• 阿得拉
• 安理申
• 艾克森
• 納門達
• 普羅維登斯
• 拉札迪因
• 利他能

第7章認知/記憶增強藥物市場：依應用分類

• 學業成績
• 運動表現
• 疾病治療

第8章北美和南美認知和記憶增強藥物市場

• 阿根廷
• 巴西
• 加拿大
• 墨西哥
• 美國

第9章亞太認知與記憶增強藥物市場

• 澳洲
• 中國
• 印度
• 印尼
• 日本
• 馬來西亞
• 菲律賓
• 新加坡
• 韓國
• 台灣
• 泰國
• 越南

第10章歐洲、中東和非洲認知與記憶增強藥物市場

• 丹麥
• 埃及
• 芬蘭
• 法國
• 德國
• 以色列
• 義大利
• 荷蘭
• 奈及利亞
• 挪威
• 波蘭
• 卡達
• 俄羅斯
• 沙烏地阿拉伯
• 南非
• 西班牙
• 瑞典
• 瑞士
• 土耳其
• 阿拉伯聯合大公國
• 英國

第11章競爭格局

• 2023 年市場佔有率分析
• FPNV 定位矩陣，2023
• 競爭情境分析
• 戰略分析和建議

公司名單

• AbbVie Inc.
• Amway Corporation
• Biogen Inc.
• Eisai Co., Ltd.
• Eli Lilly and Company
• Glanbia PLC
• Johnson & Johnson Services, Inc.
• Novartis AG
• Pfizer Inc.
• Sanofi SA
• Takeda Pharmaceutical Company Limited.
• Teva Pharmaceutical Industries Ltd.
• Unilever PLC
• WebMD LLC

The Cognitive & Memory Enhancer Drugs Market was valued at USD 5.93 billion in 2023, expected to reach USD 6.49 billion in 2024, and is projected to grow at a CAGR of 9.57%, to USD 11.25 billion by 2030.

Cognitive and memory enhancer drugs, often referred to as nootropics, are pharmaceuticals and supplements designed to improve mental performance by various mechanisms, targeting memory, attention, motivation, and other executive functions. The necessity for these drugs is underscored by increasing workloads and the aging population, prompting demand for enhanced cognitive function in both young professionals seeking an edge in competitive environments and the elderly aiming to mitigate age-related cognitive decline. End-use applications span across healthcare for treating neurological disorders such as Alzheimer's and ADHD, to use in academia and the workforce for performance enhancement. Market growth is influenced by factors such as rising awareness about mental health, technological advancements in pharmaceutical formulations, and increased investment in research and development by key players. Opportunities exist in developing compounds with fewer side effects, expanding natural and organic product lines, and targeting emerging markets in Asia and Latin America.

However, stringent regulatory frameworks and ethical concerns over the non-medical use of cognitive enhancers pose significant challenges. Side effects associated with long-term usage and the potential for misuse further hinder growth. The best areas for innovation include developing integrative solutions that combine pharmacological advancements with digital therapeutics, exploring personalized medicine approaches through genetic profiling, and enhancing delivery mechanisms for improved bioavailability. The market is competitive, marked by rapid technological exchange and a constant influx of start-ups challenging established pharmaceutical giants. Innovation and research focused on sustainable and ethically developed products will likely drive progress and acceptance. To capitalize on these opportunities, companies should invest in strategic partnerships with academia and invest in marketing to educate potential consumers on the benefits and safety of cognitive enhancers. The dynamic and evolving nature of the market demands agility and continuous adaptation to shifting consumer expectations and regulatory landscapes.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Cognitive & Memory Enhancer Drugs Market

The Cognitive & Memory Enhancer Drugs Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increasing prevalence of people suffering from neurodegenerative disorders
  • Rise in geriatric population
  • Increasing consideration of cognitive and memory enhancer drugs for academic and athletic applications
• Market Restraints
  • High cost of drug development
• Market Opportunities
  • Development of novel drugs and therapies
  • Government approval for new drug development
• Market Challenges
  • Risk of side effects

Porter's Five Forces: A Strategic Tool for Navigating the Cognitive & Memory Enhancer Drugs Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Cognitive & Memory Enhancer Drugs Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Cognitive & Memory Enhancer Drugs Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Cognitive & Memory Enhancer Drugs Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Cognitive & Memory Enhancer Drugs Market

A detailed market share analysis in the Cognitive & Memory Enhancer Drugs Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Cognitive & Memory Enhancer Drugs Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Cognitive & Memory Enhancer Drugs Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Cognitive & Memory Enhancer Drugs Market

A strategic analysis of the Cognitive & Memory Enhancer Drugs Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Cognitive & Memory Enhancer Drugs Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., Amway Corporation, Biogen Inc., Eisai Co., Ltd., Eli Lilly and Company, Glanbia PLC, Johnson & Johnson Services, Inc., Novartis AG, Pfizer Inc., Sanofi S.A., Takeda Pharmaceutical Company Limited., Teva Pharmaceutical Industries Ltd., Unilever PLC, and WebMD LLC.

Market Segmentation & Coverage

This research report categorizes the Cognitive & Memory Enhancer Drugs Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Drug Type, market is studied across Adderall, Aricept, Exelon, Namenda, Provigil, Razadyne, and Ritalin.
• Based on Application, market is studied across Academic Performance, Athletic Performance, and Disease Treatment.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing prevalence of people suffering from neurodegenerative disorders
    • 5.1.1.2. Rise in geriatric population
    • 5.1.1.3. Increasing consideration of cognitive and memory enhancer drugs for academic and athletic applications
  • 5.1.2. Restraints
    • 5.1.2.1. High cost of drug development
  • 5.1.3. Opportunities
    • 5.1.3.1. Development of novel drugs and therapies
    • 5.1.3.2. Government approval for new drug development
  • 5.1.4. Challenges
    • 5.1.4.1. Risk of side effects
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Cognitive & Memory Enhancer Drugs Market, by Drug Type

• 6.1. Introduction
• 6.2. Adderall
• 6.3. Aricept
• 6.4. Exelon
• 6.5. Namenda
• 6.6. Provigil
• 6.7. Razadyne
• 6.8. Ritalin

7. Cognitive & Memory Enhancer Drugs Market, by Application

• 7.1. Introduction
• 7.2. Academic Performance
• 7.3. Athletic Performance
• 7.4. Disease Treatment

8. Americas Cognitive & Memory Enhancer Drugs Market

• 8.1. Introduction
• 8.2. Argentina
• 8.3. Brazil
• 8.4. Canada
• 8.5. Mexico
• 8.6. United States

9. Asia-Pacific Cognitive & Memory Enhancer Drugs Market

• 9.1. Introduction
• 9.2. Australia
• 9.3. China
• 9.4. India
• 9.5. Indonesia
• 9.6. Japan
• 9.7. Malaysia
• 9.8. Philippines
• 9.9. Singapore
• 9.10. South Korea
• 9.11. Taiwan
• 9.12. Thailand
• 9.13. Vietnam

10. Europe, Middle East & Africa Cognitive & Memory Enhancer Drugs Market

• 10.1. Introduction
• 10.2. Denmark
• 10.3. Egypt
• 10.4. Finland
• 10.5. France
• 10.6. Germany
• 10.7. Israel
• 10.8. Italy
• 10.9. Netherlands
• 10.10. Nigeria
• 10.11. Norway
• 10.12. Poland
• 10.13. Qatar
• 10.14. Russia
• 10.15. Saudi Arabia
• 10.16. South Africa
• 10.17. Spain
• 10.18. Sweden
• 10.19. Switzerland
• 10.20. Turkey
• 10.21. United Arab Emirates
• 10.22. United Kingdom

11. Competitive Landscape

• 11.1. Market Share Analysis, 2023
• 11.2. FPNV Positioning Matrix, 2023
• 11.3. Competitive Scenario Analysis
• 11.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. AbbVie Inc.
• 2. Amway Corporation
• 3. Biogen Inc.
• 4. Eisai Co., Ltd.
• 5. Eli Lilly and Company
• 6. Glanbia PLC
• 7. Johnson & Johnson Services, Inc.
• 8. Novartis AG
• 9. Pfizer Inc.
• 10. Sanofi S.A.
• 11. Takeda Pharmaceutical Company Limited.
• 12. Teva Pharmaceutical Industries Ltd.
• 13. Unilever PLC
• 14. WebMD LLC

LIST OF FIGURES

• FIGURE 1. COGNITIVE & MEMORY ENHANCER DRUGS MARKET RESEARCH PROCESS
• FIGURE 2. COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DRUG TYPE, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DRUG TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. AMERICAS COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 11. AMERICAS COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. UNITED STATES COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 13. UNITED STATES COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. ASIA-PACIFIC COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 15. ASIA-PACIFIC COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. EUROPE, MIDDLE EAST & AFRICA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. EUROPE, MIDDLE EAST & AFRICA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. COGNITIVE & MEMORY ENHANCER DRUGS MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 19. COGNITIVE & MEMORY ENHANCER DRUGS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. COGNITIVE & MEMORY ENHANCER DRUGS MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. COGNITIVE & MEMORY ENHANCER DRUGS MARKET DYNAMICS
• TABLE 7. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY ADDERALL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY ARICEPT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY EXELON, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY NAMENDA, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY PROVIGIL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY RAZADYNE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY RITALIN, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY ACADEMIC PERFORMANCE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY ATHLETIC PERFORMANCE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DISEASE TREATMENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. AMERICAS COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 20. AMERICAS COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 21. AMERICAS COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 22. ARGENTINA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 23. ARGENTINA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 24. BRAZIL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 25. BRAZIL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 26. CANADA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 27. CANADA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 28. MEXICO COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 29. MEXICO COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 30. UNITED STATES COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 31. UNITED STATES COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 32. UNITED STATES COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 33. ASIA-PACIFIC COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 34. ASIA-PACIFIC COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 35. ASIA-PACIFIC COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 36. AUSTRALIA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 37. AUSTRALIA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 38. CHINA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 39. CHINA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 40. INDIA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 41. INDIA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 42. INDONESIA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 43. INDONESIA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 44. JAPAN COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 45. JAPAN COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 46. MALAYSIA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 47. MALAYSIA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 48. PHILIPPINES COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 49. PHILIPPINES COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 50. SINGAPORE COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 51. SINGAPORE COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 52. SOUTH KOREA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 53. SOUTH KOREA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 54. TAIWAN COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 55. TAIWAN COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 56. THAILAND COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 57. THAILAND COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 58. VIETNAM COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 59. VIETNAM COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 60. EUROPE, MIDDLE EAST & AFRICA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 61. EUROPE, MIDDLE EAST & AFRICA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 62. EUROPE, MIDDLE EAST & AFRICA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 63. DENMARK COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 64. DENMARK COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 65. EGYPT COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 66. EGYPT COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 67. FINLAND COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 68. FINLAND COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 69. FRANCE COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 70. FRANCE COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 71. GERMANY COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 72. GERMANY COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 73. ISRAEL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 74. ISRAEL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 75. ITALY COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 76. ITALY COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 77. NETHERLANDS COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 78. NETHERLANDS COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 79. NIGERIA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 80. NIGERIA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 81. NORWAY COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 82. NORWAY COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 83. POLAND COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 84. POLAND COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 85. QATAR COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 86. QATAR COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 87. RUSSIA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 88. RUSSIA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 89. SAUDI ARABIA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 90. SAUDI ARABIA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 91. SOUTH AFRICA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 92. SOUTH AFRICA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 93. SPAIN COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 94. SPAIN COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 95. SWEDEN COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 96. SWEDEN COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 97. SWITZERLAND COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 98. SWITZERLAND COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 99. TURKEY COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 100. TURKEY COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 101. UNITED ARAB EMIRATES COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 102. UNITED ARAB EMIRATES COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 103. UNITED KINGDOM COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 104. UNITED KINGDOM COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 105. COGNITIVE & MEMORY ENHANCER DRUGS MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 106. COGNITIVE & MEMORY ENHANCER DRUGS MARKET, FPNV POSITIONING MATRIX, 2023